The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

SNN FINANCIAL STATEMENTS

Smith & Nephew SNATS Inc — balance sheet, income statement and cash flow trends

SNNSmith & Nephew SNATS Inc

🇺🇸 USA · US · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
02 B4 B6 B202020212022202320242025

Profit Funnel

Q2 2025 · TTM
Revenue6.2 B $Gross Profit4.2 B $ · 68%Operating Income1 B $ · 16%Pre-tax Income780.8 M $ · 13%Net Income626.5 M $ · 10%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue6.2 B $+11.3%
Gross Profit4.2 B $+10.0%
Operating Income1 B $+136.6%
EBITDA1.6 B $+65.2%
Net Income626.5 M $+138.2%

Peer Comparison· Medical Devices

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
SNN6.3%68.0%25.6%10.1%
Industry median7.4%58.9%5.2%-5.7%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
05 B10 B202020212022202320242025

Capital Structure

Q2 2025
Total Assets10.5 B
  • Equity5.3 B $51%
  • Current Liabilities1.6 B $15%
  • Long-term Liabilities3.6 B $34%

Key Figures

YoY change
Total Assets10.5 B $+4.7%
Total Liabilities5.2 B $+8.3%
Total Equity5.3 B $+1.4%
Cash & ST Investments557 M $+84.4%
Total Debt3.3 B $+7.9%
Net Debt2.8 B $-0.4%

Peer Comparison· Medical Devices

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
SNN2.5762.9%1.7550.6%
Industry median3.2844.7%0.8249.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0500 M1 B202020212022202320242025

Cash Flow Bridge

Q2 2025 · TTM
0500 M1 B1.3 B $Operating-406.9 M $Investing-957.2 M $Financing-76.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow1.3 B $+111.8%
Capital Expenditures434 M $+1.6%
Free Cash Flow854 M $+371.8%
Dividends Paid-330.8 M $—

Peer Comparison· Medical Devices

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
SNN20.8%13.8%7.0%205.6%
Industry median7.2%1.5%4.1%76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on SNN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. This content is for informational purposes only and is not investment advice.